142 related articles for article (PubMed ID: 38444298)
21. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
[TBL] [Abstract][Full Text] [Related]
22. Immunological Aspects of Fulminant Type 1 Diabetes in Chinese.
Wang Z; Zheng Y; Tu Y; Dai Z; Lin J; Zhou Z
J Immunol Res; 2016; 2016():1858202. PubMed ID: 26981545
[TBL] [Abstract][Full Text] [Related]
23. Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition.
Luo S; Ma X; Li X; Xie Z; Zhou Z
Diabetes Metab Res Rev; 2020 Sep; 36(6):e3317. PubMed ID: 32223049
[TBL] [Abstract][Full Text] [Related]
24. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care.
Bending JJ; Pickup JC; Keen H
Am J Med; 1985 Dec; 79(6):685-91. PubMed ID: 3934967
[TBL] [Abstract][Full Text] [Related]
25. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
[TBL] [Abstract][Full Text] [Related]
26. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral.
Kusuki K; Suzuki S; Mizuno Y
Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673
[TBL] [Abstract][Full Text] [Related]
27. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
[TBL] [Abstract][Full Text] [Related]
28. Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy.
Zhou L; Qu H; Zhang Q; Hu J; Shou L
Front Endocrinol (Lausanne); 2023; 14():1168927. PubMed ID: 37082120
[TBL] [Abstract][Full Text] [Related]
29. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
[TBL] [Abstract][Full Text] [Related]
30. [The classification and prognostic implication of islet β cell function before and in remission period in newly diagnosed diabetic patients with ketosis].
Fan H; Zhang PR; Liu J; Xu Y
Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):108-13. PubMed ID: 22490810
[TBL] [Abstract][Full Text] [Related]
31. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
Dogan ADA; Jørgensen UL; Gjessing HJ
J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
[No Abstract] [Full Text] [Related]
32. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
[TBL] [Abstract][Full Text] [Related]
33. "Brittleness" in diabetes: easier spoken than broken.
Voulgari C; Pagoni S; Paximadas S; Vinik AI
Diabetes Technol Ther; 2012 Sep; 14(9):835-48. PubMed ID: 22731792
[TBL] [Abstract][Full Text] [Related]
34. How well are we doing? Metabolic control in patients with diabetes.
Thomsett M; Shield G; Batch J; Cotterill A
J Paediatr Child Health; 1999 Oct; 35(5):479-82. PubMed ID: 10571763
[TBL] [Abstract][Full Text] [Related]
35. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
[TBL] [Abstract][Full Text] [Related]
36. Low hemoglobin A1c levels in a patient with diabetic ketoacidosis: Fulminant type 1 diabetes mellitus.
Keskin M; Savaş-Erdeve Ş; Çetinkaya S; Aycan Z
Turk J Pediatr; 2018; 60(2):201-205. PubMed ID: 30325130
[TBL] [Abstract][Full Text] [Related]
37. Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes.
Hathout EH; McClintock T; Sharkey J; Kytsenko D; Hartwick N; Hadley-Scofield M; Torgeson S; Mace JW
Diabetes Technol Ther; 2003; 5(2):175-81. PubMed ID: 12871607
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
[TBL] [Abstract][Full Text] [Related]
39. [Clinical Analysis of 17 Adult Patients With Fulminant Type 1 Diabetes Mellitus].
Gong HP; Ren Y; Zha PP; Chen DW; Gao Y; Huang H; Wang C
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):653-658. PubMed ID: 37248600
[TBL] [Abstract][Full Text] [Related]
40. [Case of fulminant type 1 diabetes mellitus complicated with acute renal failure treated with continuous hemodiafiltration].
Fujinaga A; Terao Y; Tanabe T; Yamasiita K; Ando Y; Fukusaki M
Masui; 2007 Feb; 56(2):175-7. PubMed ID: 17315734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
